C3 and Alzheimer disease: Strikingly, inhibition of C1q, C3 or the microglial complement receptor CR3 reduces the extent of synapse loss in these AD models, suggesting that microglia eliminate synapses through a complement-dependent mechanism in AD models prior to plaque formation [54].